Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Ucom Continues Large-Scale Network Modernization, Expanding 5G Coverage and Enhancing Connectivity EBRD’s AMD-denominated bonds listed on AMX; Converse Bank acted as underwriterBecome a Unibank shareholder and acquire perpetual bonds with a 13.25% yieldThe Unprecedented Educational Summer of the 'Armenian Virtuosos'All Armflix Content Is Once Again Available on UplayHayk Melikyan Opens the 5th Festival of Armenian Culture in KatowiceHarutyun Harutyunyan: “The Government Has No Intention of Applying for EU Membership and Adopted the Law to Prevent a Referendum”Ucom Supports Coca-Cola Fest 2026 “Orran” Students Start the New Academic Year with Support from “The Power of One Dram”It is with deep awareness of the seriousness of this supposition as well as concern that we pose the question of the above headline“Armenian Virtuosos” Scholarship Recipients Take the Stage at the 4th International Festival of Youth Orchestras of the WorldUnibank Launches a New Promotion "U-Teenager": Grand Prize — a Summer Course at One of the Top Universities AbroadSEROOND Begins: Armenia’s First Authored School Model Based on Whole-Child Development, Enabled by AI"Unisport" Advances to the Main Round of the UEFA Futsal Champions League Cybersecurity Course Graduates Take Part in Ucom’s “Junior Academy” ProgramUcom Introduces Green Tariff Plans, Turning Everyday Connectivity into Environmental Impact Ucom Launches “Unity Back to School” Special Offer for the New School YearUcom’s Sales and Service Center Reopens at 7 Sayat-Nova Street in Gyumri "Unisport" Competes in the UEFA Futsal Champions LeagueAram Barseghyan Appointed CEO of Team Telecom Armenia, Hayk Yesayan to Lead Team Group
Life

Paracetamol claimed to be ineffective against most types of pain, study claims

Paracetamol is one of the most popular drugs that people take to combat pain or fever, but it is claimed to be ineffective against most types of pain.

Scientists at Sydney's University analyzed systematic reviews of 3,570 studies that looked at the efficacy and safety of paracetamol for treating 44 types of pain conditions. Meanwhile, a single or multiple intake of a standard dose of a popular drug (0.5-1 g) is superior to placebo only for 4 painful conditions - osteoarthritis of the knee and hip joints, recovery from the craniotomy, pelvic pain, including postpartum pain, and headache voltage.

For common conditions such as migraines and headaches with colds, as well as low back pain, the evidence for the effectiveness of paracetamol was too low or inconclusive.

Scientists questioned the recommendation of taking paracetamol for pain in the lumbosacral region back in 2016 when a randomized placebo-controlled trial involving 1,652 patients found no difference between the popular pain reliever and placebo.